KATNAL2
protein-codingkatanin catalytic subunit A1 like 2, the group of AAA ATPases
Gene summary
Predicted to enable ATP hydrolysis activity. Predicted to be involved in meiotic spindle organization and microtubule severing. Located in cytoplasm and cytoskeleton. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~186.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
Variants in *KATNAL2* have been reported in numerous individuals with complex neurodevelopmental disorders, including autism spectrum disorder (PMIDs: 22495306, 22495309, 22495311, 25363760, 25621899, 28191889, 30504930, 31209962, 31398340, 31981491, 32094338) and intellectual disability (PMIDs: 28191889, 31209962, 32094338); the first reports were published in autism in 2012 (PMIDs: 22495306, 22495309, 22495311). At least 32 variants have been reported (3 nonsense, 5 frameshift, 5 splice site, 17 missense, and 2 CNV deletions); 4 were *de novo*, 12 inherited (including 7 truncating variants), and 6 were of unknown inheritance. It is unlikely that these variants are the cause for the neurodevelopmental disorders present in these individuals. In many of the reported cases, the variants are inherited from parents that are either reportedly unaffected or have no phenotype information, they do not segregate with disease (PMIDs: 25621899, 28191889, 32094338), or are present in population databases at frequencies too high to be causative of disease (PMIDs: 25363760, 28191889, 31209962). In addition, *KATNAL2* truncating variants have been reported in control subjects (PMIDs: 25363760, 30208311, 31981491). Further, per data from gnomAD, *KATNAL2* appears to be tolerant of variation in general - the gene is not constrained for either missense or protein truncating variants. This makes it difficult to discern a potential disease mechanism and raises the question of whether the variants reported in the affected individuals occurred just by chance. In summary, the evidence supporting the relationship between *KATNAL2* and autosomal dominant complex neurodevelopmental disorders has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *KATNAL2* plays in this disease. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 20, 2020 (SOP Version 7). As of August 2026, this record underwent administrative updates to update scoring to be consistent with SOP Version 12. No new evidence has been reviewed or added.
Inheritance Pattern: AR
Disease ID:MONDO:0005372
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KATNAL2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001387690.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 17 | 1 | 18 | |||
| missense | 88 | 12 | 2 | 102 | ||
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 3 | 3 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 95 | 29 | 3 | 127 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001374619.1 | 16 | MANE Select | |
| Ensembl | ENSP00000508137.1 | 16 | MANE Select | |
| RefSeq | NP_001340828.1 | 17 | Standard | |
| RefSeq | NP_001340829.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- cytoplasmic microtubule organization
- microtubule severing
Molecular Function
- protein binding
- ATP binding
- microtubule binding
- microtubule-severing ATPase activity
- isomerase activity
Cellular Component
- spindle pole
- nucleus
- cytoplasm
- spindle
- microtubule
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000245121
- Coding exons
- 14
- Length
- 130204
- Individuals with no LoFs
- 125644
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 104
- Defined
- 125748
- p
- 0.000414
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.421 | 244 | 263 | 0.927 | 0.0000147 | 3030 |
| Missense (PolyPhen) | 75 | 101.52 | 0.73879 | 1188 | ||
| Synonymous | -1.31 | 115 | 98.5 | 1.17 | 0.00000559 | 880 |
| Loss of Function | 2.29 | 14 | 26.8 | 0.522 | 0.00000142 | 319 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00061 | 0.00061 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0026 | 0.0026 | notable |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00018 | 0.00018 | rare |
| South Asian | 0.00030 | 0.00029 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Severs microtubules in vitro in an ATP-dependent manner. This activity may promote rapid reorganization of cellular microtubule arrays. {ECO:0000255|HAMAP-Rule:MF_03025}.;
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- LoFtool
- 0.208
- RVIS EVS
- -1.09
- RVIS percentile EVS
- 7.11
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.209
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |